Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$212K Buy
+3,376
New +$209K 0.01% 226
2024
Q2
Sell
-3,760
Closed -$217K 214
2024
Q1
$217K Buy
+3,760
New +$194K 0.01% 207
2023
Q4
Sell
-4,368
Closed -$223K 220
2023
Q3
$223K Hold
4,368
0.01% 192
2023
Q2
$250K Buy
4,368
+437
+11% +$25.5K 0.02% 188
2023
Q1
$237K Sell
3,931
-3,708
-49% -$226K 0.02% 132
2022
Q4
$449K Buy
7,639
+37
+0.5% +$2.34K 0.03% 104
2022
Q3
$435K Buy
7,602
+400
+6% +$23.3K 0.03% 104
2022
Q2
$390K Buy
7,202
+3,708
+106% +$215K 0.03% 119
2022
Q1
$200K Buy
+3,494
New +$179K 0.01% 138

Other funds holding CTVA

Sabal Trust's CTVA Position: Q1 2025 in Review

Sabal Trust opened a new position in Corteva (CTVA) in Q1 2025: 3,376 shares worth $212K. The stake represents 0.01% of the portfolio and ranks #226 among its holdings. This is a return to the name: Sabal Trust previously reported a position in CTVA as recently as Q1 2024.

Sabal Trust first reported a position in CTVA in Q1 2022 and has held it in 9 quarters since. The position peaked at $449K in Q4 2022. 1,323 funds tracked by Wall St. Rank hold CTVA as of Q1 2025.

  • Sabal Trust held 3,376 shares of Corteva worth $212K as of Q1 2025.
  • Corteva was a new Sabal Trust position in Q1 2025.
  • Corteva made up 0.01% of Sabal Trust's portfolio in Q1 2025, its #226 holding.
  • Sabal Trust first reported a position in Corteva in Q1 2022 and has held it in 9 quarters since.
  • Sabal Trust's Corteva position peaked at $449K in Q4 2022.
  • 1,323 funds tracked by Wall St. Rank held Corteva as of Q1 2025.

Based on Sabal Trust's 13F filing for Q1 2025, filed 23 Apr 2025.